Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...
FDA’s Rare Disease Innovation Hub Releases Strategic Agenda: Implications for Stakeholders in 2025
In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
Breadcrumbs sold for months throughout the United States contain an undeclared allergen and are being recalled for safety reasons, the Food and Drug Administration announced on its website on Jan. 28.
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...
The center of excellence, meanwhile, was first launched as a coordinating hub within the CDRH in late 2020. FDA joins international push for transparency in AI development In his farewell post ...
The FDA says the cybersecurity vulnerabilities identified may put patients at risk when the device is connected to the internet.
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...
It is critical that agencies mandated to protect public health, such as the Food and Drug Administration (FDA), maintain their authority to ensure these products meet high safety standards that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback